---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-061150"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2021-12-23T23:59:59+00:00"
generated_at: "2026-06-27T22:37:19.004051+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Director William R. Enquist, Jr. resigns from Ra Medical board effective Dec 31, 2021

## Summary
- Enquist resigned due to California board gender diversity law (Corp. Code §301.3); no disagreement with company.
- Compensation Committee after resignation: Martin Colombatto (Chair) and Susanne L. Meline.
- Board appointed Colombatto to Nominating and Corporate Governance Committee, now: Joan Stafslien (Chair) and Colombatto.
- Audit Committee unchanged: Richard Mejia, Jr. (Chair) and Joan Stafslien; all committee members independent per NYSE American.

## SEC filing metadata
- accession: 0001564590-21-061150
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2021-12-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000156459021061150/0001564590-21-061150-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000156459021061150/rmed-8k_20211217.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-061150
- JSON: https://secwatch.observer/filing/0001564590-21-061150.json
- Plain text: https://secwatch.observer/filing/0001564590-21-061150.txt

## Key facts
- Executive change
  William R. Enquist, Jr. resigned as Director at Catheter Precision, Inc..
  - Action: resigned
  - Role: Director
  source text: On December 17, 2021, William R. Enquist, Jr. notified Ra Medical Systems, Inc. (the “Company”) that, effective December 31, 2021, he is resigning from the Company’s Board of Directors (the “Board”) as well as from the Nominating and Corporate Governance Committee and the Compensation Committee.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000156459021061150/0001564590-21-061150-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.